期刊文献+

乳头状肾细胞癌8例临床病理分析 被引量:2

Clinical pathological analysis of 8 cases of papillary renal cell carcinoma
下载PDF
导出
摘要 目的探讨乳头状肾细胞癌(PRCC)的临床病理特点、诊断及鉴别诊断要点。方法回顾分析8例乳头状肾细胞癌的临床资料、病理学特点及免疫组化表型。结果8例中有2例为女性,年龄在45—63岁之间。5例为右肾,3例为左肾。主要临床表现为腰部疼痛。光镜下PRCC主要由恶性上皮细胞构成的多少不等的小管和乳头状结构。免疫组化:肿瘤细胞PCK(+),CK7(+),CK8(+),EMA(+),S-100(+),Vimentin(+),CD10(-)。结论乳头状肾细胞癌明确诊断需结合病理学特点及免疫表型,且需要与肾脏其他肿瘤进行鉴别。 Objective To explore the clinical and pathological features, differential diagnosis of papil- lary renal cell carcinoma(PRCC). Methods Retrospectively analyze 8 cases of PRCC for their clinical data, pathological features and immunohistochemistry phenotype. Results 2 of the patients were female whose ages ranged from 45 to 63. Five tumors were located in the right kidney and other three in the left kidney. The major clinical manifestation of the eight PRCC was the waste pain. The tumor histo|ogic architecture was papillary or tubupapilary, immunohistochemically, CK7, CK8, EMA and Vimentin were positive in the eight cases. CDIO was negative. Conclusion The diagnose of PRCC depends on pathological characteristics and expression of im- munohistochemistry.
出处 《中国现代药物应用》 2014年第1期27-28,共2页 Chinese Journal of Modern Drug Application
关键词 乳头状肾细胞癌 免疫组化 Peripheral primitive neuroectodermal tumor Immunohistochemistry
  • 相关文献

参考文献4

  • 1Lubensky IA,Schmidt L,Zhuang Z. Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype[J].{H}AMERICAN JOURNAL OF PATHOLOGY,1999,(02):517-526.
  • 2Sanders ME,Mick R,Romzszewski JE. Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic Papillary renal cell carcinoma[J].{H}AMERICAN JOURNAL OF PATHOLOGY,2002,(03):997-1005.
  • 3Marshall FF,Powell KC. Lymphadenectomy for renal cell carcinoma.Anatomical and therapeutic considerations[J].{H}Journal Of Urology,1982,(04):677-681.
  • 4Phillips E,Messing EM. Role of lymphadenectomy in the treatment of renal cell carcinoma[J].{H}UROLOGY,1993,(01):9-15.

同被引文献23

  • 1刘旮,傅龙龙,余月,王义兵,傅斌,王共先.32例乳头状肾细胞癌临床诊治分析[J].微创泌尿外科杂志,2013,2(5):328-330. 被引量:3
  • 2孙桢,夏庆华.肾癌不同病理亚型的MRI特点[J].泌尿外科杂志(电子版),2014,6(2):29-32. 被引量:5
  • 3Novara G, Martignoni G, Artibani W, et al. Grading systems in renal cell carcinoma [J]. J Urol, 2007,177 ( 2 ) : 430-436.
  • 4Schrader AJ, Rauer-Bruening S, Olbert PJ, et al. Incidence and long-term prognosis of papillary renal cell carcinoma [J]. J Cancer Res Clin Oncol,2009,135(6):799-805.
  • 5Qu Y,Chen H, Gu W,et al. Age-Dependent association be- tween sex and renal cell carcinoma mortality:a population- based analysis[ J]. Sci Rep,2015 ,5 :9160.
  • 6Hashimoto Y, Takagi T, Kondo T, et al. Comparison of prog- nosis between patients with renal cell carcinoma on hemodi- alysis and those with renal cell carcinoma in the general population[ J]. Int J Clin Oncol,2015,20(4) :641-649.
  • 7Alshenawy HA. Immunohistochemical panel for differentia- ting renal cell carcinoma with clear and papillary features [J]. Pathol Oncol Res,2015,2l (4) :893-899.
  • 8Polcari AJ, Gorbonos A, Milner JE, et al. The role of cytore- ductive nephrectomy in the era of molecular targeted thera- py[J]. Int J Urol,2009,16(3) :227-233.
  • 9Gore ME, Szczylik C, Porta C, et al. Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded- access trial [J]. Lancet Oncol, 2009,10 ( 8 ) : 757-763.
  • 10Dutcher JP, de Souza P, McDermott D, et al. Effect of tem- sirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histol- ogies[J]. Med Oncol,2009,26(2) :202-209.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部